Sarah Cannon Research Institute at Tennessee Oncology — Nashville, Tennessee

Sarah Cannon Research Institute at Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at Tennessee Oncology has participated in 22 clinical trials with 3 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Solid Tumor, Adult, Metastatic Cancer.

Sponsors: Verastem, Inc., Fochon Pharmaceuticals, Ltd., Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at Tennessee Oncology?

Sarah Cannon Research Institute at Tennessee Oncology has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at Tennessee Oncology conducted?

Sarah Cannon Research Institute at Tennessee Oncology has 22 clinical trials on record, with 3 currently active. Their work covers Epithelial Ovarian Cancer, Solid Tumor, Adult, Metastatic Cancer.

Is Sarah Cannon Research Institute at Tennessee Oncology accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute at Tennessee Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute at Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.